Top Companies in Prenatal Genetic Testing Market by Size, Share, Historical and Future Data & CAGR | Report by Vantage Market Research

Vantage Market Research has recently published a new report on the “Prenatal Genetic Testing Market” Global Industry Assessment & Forecast to identify key trends and challenges. This report offers insights into the competitive landscape, prospects, and key investment considerations for businesses operating in the Prenatal Genetic Testing market. Some of the key statistics in this report highlight that the global prenatal genetic testing market was valued at USD 9.5 Billion in 2022 and is expected to reach USD 24.9 Billion by the year 2030 at a CAGR of 14.8% over the forecast period. The global Prenatal Genetic Testing market will continue to expand due to rising demand from different end-user sectors, including hospitals and clinics, diagnostic laboratories, and research institutes, and direct-to-consumer (DTC) testing.

Request Sample Report of Prenatal Genetic Testing Market @ https://www.vantagemarketresearch.com/prenatal-genetic-testing-market-2144/request-sample

The market is highly competitive and consists of several key players. Some of the leading companies in the Prenatal Genetic Testing market include Illumina (U.S.), Natera (U.S.), PerkinElmer (U.S.), Quest Diagnostics (U.S.), Roche Diagnostics (Switzerland), Agilent Technologies (U.S.), BGI Genomics (China), Berry Genomics (China), Eurofins LifeCodexx (Germany), and Laboratory Corporation of America Holdings (LabCorp) (U.S.). These companies have a significant presence in the market and offer a range of prenatal genetic testing services and products, such as non-invasive prenatal testing (NIPT) and carrier screening tests. They are also investing heavily in research and development to develop new and advanced technologies for prenatal genetic testing.

Let’s Take a Look at the Top Market Players that are Captivating the Prenatal Genetic Testing Market

1. Illumina Inc. (U.S.)

Illumina, Inc. is an American company that specializes in DNA sequencing and genetic analysis. Founded in 1998, Illumina has since become a leader in genomics with its innovative technologies and wide range of products for genetic analysis. The company operates in over 100 countries, serving customers in the academia, government, and private industry sectors. The company's prenatal genetic testing products include the VeriSeq NIPT Solution, a non-invasive prenatal test that screens for chromosomal abnormalities in the developing fetus. This testing solution uses Illumina's proprietary NextSeq 500 Sequencing System and offers fast, accurate, and reliable results for pregnant women. Illumina's prenatal genetic testing solutions are designed to support doctors and clinicians in making informed decisions about managing a pregnancy, identifying potential health risks, and developing appropriate treatment plans. The company is committed to advancing genomic technologies and research to improve human health and is continually developing new products and tools for genetic analysis.

2. Natera Inc. (U.S.)

Natera, Inc. is a leading player in the prenatal genetic testing market, which involves the detection of genetic abnormalities in fetuses during pregnancy. The company was founded in 2004 and is headquartered in San Carlos, California, U.S. Natera's core technology platform is called the Panorama test, which is a non-invasive prenatal test (NIPT) that analyzes cell-free DNA (cfDNA) in the mother's blood to detect fetal chromosomal abnormalities and genetic conditions. The Panorama test has a high accuracy rate and can detect conditions such as Down syndrome, Edwards syndrome, and Patau syndrome. In addition to the Panorama test, Natera also offers other prenatal genetic tests, such as the Vistara test for preimplantation genetic screening (PGS) and the Horizon carrier screening test. The company partners with various healthcare providers and laboratories to offer its tests worldwide. Through mergers and acquisitions, Natera has been expanding its presence in the prenatal genetic testing market. In 2018, the company acquired the reproductive genetics laboratory, Evercord, to expand its stem cell banking services offering. In 2020, Natera acquired SharedLABS, a provider of genetic testing services, to enhance its diagnostic capabilities. In addition to its prenatal genetic testing business, Natera offers genetic testing services for oncology, organ transplantation, and women's health.

3. PerkinElmer Inc. (U.S.)

PerkinElmer, Inc. is a leading global provider of solutions and services in the life sciences, diagnostics, and applied markets. The company is headquartered in Waltham, Massachusetts, U.S. In the field of prenatal genetic testing, PerkinElmer provides a range of solutions, including maternal serum screening, non-invasive prenatal testing (NIPT), and diagnostic testing for genetic disorders. The company's NIPT solution is called the Vanadis Test, a highly accurate and non-invasive blood test for detecting fetal trisomies (including Down syndrome) and other chromosomal abnormalities. PerkinElmer also offers diagnostic testing for genetic disorders through its GSP® Neonatal platform, providing rapid and reliable results for various genetic diseases.

4. Quest Diagnostics Inc. (U.S.)

Quest Diagnostics Inc. is a leading diagnostic testing, information, and services provider headquartered in New Jersey, USA. The company offers various laboratory and clinical services, including advanced diagnostics, genomic testing, and clinical trials. With a presence in more than 50 countries, Quest Diagnostics supports patients and physicians worldwide. In the field of prenatal genetic testing, Quest Diagnostics provides a comprehensive range of tests to diagnose various genetic disorders that can affect a developing fetus. These tests include non-invasive prenatal testing (NIPT), carrier screening, and diagnostic testing. With a strong focus on innovation & research, Quest Diagnostics has been at the forefront of developing advanced technologies and tests for prenatal genetic screening. As a result, the company's tests are highly accurate, reliable, and scalable, making them accessible to many patients worldwide. In addition, Quest Diagnostics has a team of experienced genetic counselors who assist patients in understanding their test results and making informed decisions about their pregnancies.

5. Roche Diagnostics (Switzerland)

Roche Diagnostics is a Switzerland-based healthcare company that offers innovative medical solutions in diagnostics and pharmaceuticals. The company was founded in 1896 and has since become a global healthcare industry leader. Prenatal genetic testing is one of the areas where Roche Diagnostics specializes. The company offers a range of prenatal genetic tests, which help expectant parents determine if their unborn child is at risk of genetic disorders. These tests can identify chromosomal abnormalities, genetic syndromes, and inherited diseases. In addition, Roche Diagnostics offers a non-invasive prenatal test (NIPT), a blood test that analyses the baby's DNA in the mother's blood. This test is highly accurate and considered the best option for detecting chromosomal abnormalities in the fetus. Aside from NIPT, Roche Diagnostics offers other prenatal genetic tests, including chromosomal microarray analysis (CMA) and carrier screening tests. These tests can identify various genetic disorders and provide parents with valuable information about their baby's health.

6. Agilent Technologies Inc. (U.S.)

Agilent Technologies, Inc. is a diversified life sciences company headquartered in California, United States. The company operates in four segments: life sciences and applied markets, diagnostics and genomics, chemical analysis, and cross-lab. The company provides life sciences research tools and diagnostics solutions, including instruments, software, consumables, and services to pharmaceutical and biotechnology companies, academic institutions, researchers, hospitals, and government agencies. Agilent Technologies, Inc. offers comprehensive solutions to improve patient outcomes and optimize laboratory efficiency. Its prenatal genetic testing portfolio includes highly accurate screening assays for fetal aneuploidies, microdeletions, and common chromosomal abnormalities. Agilent's SureSelect XT HS DNA Library Prep Kit and SureCall software provide reliable and improved sequencing data analysis and management of fetal samples. The company also offers other genomic and cytogenetic analysis solutions, including comparative genomic hybridization (CGH) arrays, fluorescence in situ hybridization (FISH), and real-time PCR-based assays. Agilent's precision medicine solutions leverage next-generation sequencing (NGS) and other technologies to provide comprehensive genomic profiling of patients for personalized treatment and diagnosis of diseases.

7. BGI Genomics (China)

BGI Genomics is a leading company in genetic sequencing and analysis. It was founded in 1999 in Beijing, China, and has since expanded its operations to other parts of the world. BGI Genomics provides a wide range of genomic services, including next-generation sequencing, bioinformatics, and clinical genetic testing. One of the key areas of focus for BGI Genomics is prenatal genetic testing. The company offers a range of tests that can be used to identify genetic risks and abnormalities in the fetus during pregnancy. These tests include non-invasive prenatal testing (NIPT), which uses a small sample of maternal blood to screen for fetal chromosomal abnormalities. BGI Genomics is well-positioned to take advantage of this growing market, thanks to its expertise in genetic sequencing and analysis and its extensive network of partnerships with healthcare providers and research institutions around the world. The company's commitment to advancing the field of prenatal genetic testing has helped it become a leader in this important area of healthcare.

8. Berry Genomics (China)

Berry Genomics is a China-based biotechnology company specializing in genetic testing solutions. The company offers a comprehensive range of prenatal genetic testing services, including non-invasive prenatal testing (NIPT), carrier screening, and diagnostic testing for genetic disorders. Berry Genomics was founded in 2010 and has become a leading Chinese genetic testing market player. The company has established partnerships with major hospitals and medical institutions in China and collaborations with international companies and research institutions. In addition to its prenatal genetic testing services, Berry Genomics also offers genetic testing for cancer, rare diseases, and pharmacogenetics. The company's mission is to use genetic testing to improve the accuracy of diagnostics and personalized medicine and ultimately advance human health. Berry Genomics is well positioned to capitalize on this trend, with its strong reputation for quality and extensive partnerships and collaborations.

9. Eurofins LifeCodexx (Germany)

Eurofins LifeCodexx is a subsidiary of the Eurofins Scientific group, a global leader in bioanalytical testing. LifeCodexx focuses on non-invasive prenatal testing (NIPT) and offers a range of tests for genetic disorders such as Down syndrome, Edwards syndrome, and Patau syndrome. Eurofins LifeCodexx is well-positioned to capitalize on this growth, with a strong focus on research and innovation in prenatal genetic testing. The company has developed proprietary technology for NIPT, including the innovative Next Generation Sequencing (NGS) platform, which allows for more accurate and reliable results. In addition to its strong presence in Europe, Eurofins LifeCodexx has expanded its operations into Asia and the Middle East. The company also has partnerships with leading healthcare providers and clinics worldwide, making its testing services widely accessible to pregnant women.

10. Laboratory Corporation of America Holdings (LabCorp) (U.S.)

Laboratory Corporation of America Holdings (LabCorp) is a leading global life sciences and diagnostics company that offers a broad range of laboratory testing services. Its offerings include a comprehensive range of prenatal genetic testing that helps clinicians assess the risk of genetic disorders in fetuses during pregnancy. The company's prenatal genetic testing services cover a wide range of genetic disorders that include Down syndrome, cystic fibrosis, and spina bifida, among others. LabCorp was founded in 1978 and is headquartered in Burlington, North Carolina. It has over 70,000 employees and operates in more than 60 countries worldwide. The company is listed on the New York Stock Exchange (NYSE) under the ticker symbol "LH" and has a market capitalization of over $25 billion as of 2021. In the field of prenatal genetic testing, LabCorp has established itself as a leading player with its comprehensive range of tests and services. Its prenatal testing services include non-invasive prenatal testing (NIPT), carrier screening, and diagnostic testing. LabCorp's NIPT, known as the Harmony Prenatal Test, is a susceptible and specific screening test that detects fetal DNA in the mother's blood. The test has a high detection rate for fetal chromosome abnormalities, including Down syndrome, Edwards syndrome, and Patau syndrome.

Read Our Latest Blog: Top Companies in Multiple Myeloma Market

Do You Have Any Queries or Specific Requirements? You may enquire to our sales team before purchasing.

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: [email protected]

Website: Vantage Market Research

Vantage Market Research Blogs